Breaking News, Promotions & Moves

Cytovance Biologics

New appointments as Cytovance expands in international markets

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cytovance Biologics is launching dedicated business development activities in international markets for biologic contract manufacturing of therapeutic proteins and monoclonal antibodies. Molly S. McGlaughlin MeD, has been appointed to the newly created position of vice president of Sales & Business Development – International, and will be spearheading this critical strategic growth initiative. Ms. McGlaughlin joined Cytovance in 2008 as vice president of Sales & Business Development; she...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters